Navigation Links
ConvaTec and HemCon Announce Co-Promotion Agreement

Medical Innovators Partner to Bring Advanced Wound and Critical Care Products to U.S. Armed Forces

SKILLMAN, N.J., April 15 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a co-promotion agreement with HemCon Medical Technologies Inc. to market ConvaTec advanced wound and critical care products to the U.S. Armed Forces.

Through the agreement, HemCon, a leading global developer of advanced medical products, is granted sales and marketing rights to leading ConvaTec products, the company's AQUACEL(R) and AQUACEL(R) Ag dressings for managing acute and chronic wounds and its Flexi-Seal(R) Fecal Management System (FMS) for the management of fecal incontinence.

AQUACEL(R) and AQUACEL(R) Ag dressings feature the unique benefits of Hydrofiber(R) Technology. These dressings gel on contact with wound fluid to provide a moist wound healing environment, manage exudate, protect the periwound skin(1) and reduce pain in situ and on removal.(2),(3),(4) In addition, AQUACEL(R) Ag dressing provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) as demonstrated in vitro.(5)

The innovative Flexi-Seal(R) FMS, a temporary containment device for patients with acute fecal incontinence, was designed to safely and effectively divert fecal matter, protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as Clostridium difficile (C. difficile).

"ConvaTec is proud to be partnering with HemCon to bring our advanced wound and critical care products to the U.S. Armed Forces," commented Michael Steadman, President, Wound Therapeutics and ConvaTec USA. "We hope this agreement also will form the basis of similar initiatives to expand our presence in specialized, acute care settings."

"This new arrangement with ConvaTec will provide the U.S. Armed Forces with the support and products they need to enable safer, more stable recoveries," said Bill Block, President, HemCon U.S. "As a trusted, proven Military partner, HemCon continues to pioneer and deliver new products for wound care and healing that bring innovative solutions to the Military and deliver medical technologies when and where they are needed most."

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit

About HemCon Medical Technologies

HemCon Medical Technologies Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances including Lyophilized Human Plasma and Nanospider(TM) technologies. HemCon is headquartered in Portland, OR, with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit


  1. Robinson BJ. The use of a Hydrofiber(R) dressing in wound management. J Wound Care 2000;9(1):32-34.
  2. Armstrong SH, Brown DA, Hill E, Ruckley CV. A randomized trial of a new Hydrofiber(R) dressing, AQUACEL(R), and an alginate in the treatment of exuding leg ulcers. Presented at: 5th European Conference on Advances in Wound Management; Harrogate, UK: November 1995.
  3. Caruso DM, Foster KN, Blome-Eberwein SA et al. Randomized clinical study of Hydrofiber(R) dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J Burn Care Res. 2006; 27(3):298-309.
  4. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J. Comparative study of Aquacel(R) and Silverol(R) treatment in burns. Ann Burns Fire Disasters. 2004; 17(4):201-207.
  5. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber(R) dressing. Wound Repair Regen. 2004;12(3):288-294.

AQUACEL, Hydrofiber, and FlexiSeal are registered trademarks of ConvaTec Inc.

Our world is what we make of it is a trademark of ConvaTec Inc.

(C)2009 ConvaTec Inc.



    Punnie Donohue

    Nicole Elovitz
    HemCon Medical Technologies, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the ... in scientific research and discoveries, leading us to better understand the disease’s behavior. ... those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight ...
(Date:12/1/2015)... ... ... It’s official: Tattoo taboo is a thing of the past. One in ... whopping one in three aged 18 to 25 is inked). As tattoos transition to ... In fact, RealSelf , the world’s largest community for learning and sharing information ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken at ... accurate interpretation by the radiologist. The marking utensils are so small, however, they ... found a way to alleviate this problem. , He developed the patent-pending MARK ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 WellStar Health System has ... Texas -based Tenet Healthcare,s five metro ... approved the strategic move following the conclusion of the ... clinical care models and patient safety programs that have ... to new communities. --> ...
(Date:12/1/2015)... 2015  Eyeon Therapeutics has received a Notice ... based on a charged hydrophilic polymer developed at ... product has been shown to be safe and ... Mark Mitchnick , MD, CEO states, "This second ... polymers in conjunction with a therapeutic agent.  Nanoparticles ...
(Date:12/1/2015)... 1, 2015 Pharma Tech Outlook recently conducted ... Clinical Data Management Solution Providers - 2015 .  After ... comprising CEOs, CIOs, VCs, analysts, and the Pharma Tech ... of top 10 clinical data management solution providers (check ... 14 and 36 respectively). --> ...
Breaking Medicine Technology: